CCN3
CCN3 (cellular communication network factor 3) is a small, secreted, cysteine-rich member of the CCN family of regulatory proteins. Also known as NOV, IGFBP9 and nephroblastoma overexpressed, it acts as an immediate-early protein in proliferation, adhesion, migration, differentiation and survival. Browse Assay Genie's current range of CCN3 research reagents below, or read on for the biology behind the target.
CCN3 is an immediate-early protein that influences proliferation, adhesion, migration, differentiation and survival. It acts by binding to integrins or to membrane receptors such as NOTCH1. It is a ligand of the integrins ITGAV:ITGB3 and ITGA5:ITGB1, through which it acts directly on endothelial cells to stimulate pro-angiogenic activity, support adhesion, induce chemotaxis and promote survival. In skin, it supports fibroblast adhesion through ITGA5:ITGB1 and ITGA6:ITGB1, induces fibroblast chemotaxis through ITGAV:ITGB5, and contributes to cutaneous wound healing.
The CCN3 protein is also an essential regulator of haematopoietic stem and progenitor cell function. It inhibits myogenic differentiation through activation of Notch signalling, and restrains vascular smooth muscle cell proliferation by raising expression of cell-cycle regulators such as CDKN2B and CDKN1A, independently of TGFB1 signalling. It negatively regulates endothelial pro-inflammatory activation and reduces monocyte adhesion through inhibition of NF-kappaB signalling. It attenuates inflammatory pain by regulating IL1B- and TNF-induced MMP9, MMP2 and CCL2 expression, and inhibits MMP9 through ITGB1 engagement. In the pancreas it impairs beta-cell function, proliferation and insulin secretion.
In bone and cartilage, CCN3 is a negative regulator of bone regeneration, favours the articular chondrocyte phenotype over endochondral ossification, and is described as a brain osteoanabolic hormone that drives osteogenesis in osteochondral skeletal stem cells. During lactation it helps maintain the maternal skeleton and offspring viability. UniProt lists it as secreted, with cytoplasmic and gap junction localisation. The CCN3 gene encodes a protein that, like other CCN members, associates with the extracellular matrix and is linked to cardiovascular and skeletal development, fibrosis and cancer development. Mouse and rat orthologues are named Ccn3.
CCN3 binds integrins on endothelial cells to promote adhesion, chemotaxis, survival and angiogenesis, making it a useful subject for vascular studies.
CCN3 negatively regulates bone regeneration, supports the articular chondrocyte phenotype and drives osteogenesis in osteochondral skeletal stem cells.
CCN3 suppresses endothelial pro-inflammatory activation via NF-kappaB inhibition and modulates IL1B- and TNF-induced MMP9, MMP2 and CCL2 expression.
CCN3 is an essential regulator of haematopoietic stem and progenitor cells and signals through NOTCH1 and integrins.
CCN3 is a secreted regulatory protein that binds integrins and receptors such as NOTCH1. It influences proliferation, adhesion, migration, differentiation and survival, and has roles in angiogenesis, wound healing, bone and cartilage biology, haematopoietic stem cell function and the control of inflammation.
The gene was originally named nephroblastoma overexpressed (NOV), and IGFBP9 is a previous symbol. HGNC now designates it CCN3, cellular communication network factor 3, within the cellular communication network factors group. UniProt lists the protein as CCN family member 3.
Yes. Mouse and rat both have an orthologous gene named Ccn3, so the protein can be studied in rodent models. Researchers should check the datasheet of any product for its validated reactivity.
Other CCN family members that associate with the extracellular matrix and regulate cell communication.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P48745; product specifications from Assay Genie datasheets.